Association between anemia severity and migraine in iron deficiency anemia

dc.contributor.authorSari, U.S.
dc.contributor.authorBaşcı, Ö.K.
dc.date.accessioned2025-07-03T21:17:49Z
dc.date.issued2024
dc.departmentBalıkesir Üniversitesi
dc.description.abstractOBJECTIVE: Migraine is an episodic public health problem that usually occurs with a severe headache. Various mechanisms and outcomes have been reported between iron deficiency anemia (IDA) and migraine. We aimed to investigate the effect of the presence and severity of anemia and iron parameters on the frequency and severity of migraine attacks. PATIENTS AND METHODS: The study included 104 patients with IDA and newly diagnosed migraine in the neurology outpatient clinic and 38 age and gender-matched controls with normal hemoglobin levels. Patients were divided into 3 subgroups (mild, moderate, and severe anemia) to determine a significant relationship between the severity of IDA and migraine attacks. All patients were asked validated questions with the Visual Analogue Scale (VAS), Headache Impact Test-6 (HIT-6), and the Hamilton Anxiety Rating Scale (HAM-A) face-to-face. RESULTS: In this study, 85.6% of the participants were female, and 22 (14.6%) of them were male. Thirty-two mild anemia patients’ mean age was 36.6 ± 12.5, 41 with moderate anemia was 46 ± 14.2, and 31 with severe anemia patients’ mean age was 48 ± 14.1. There was no significant difference between the subgroups in VAS, HIT-6 score, headache type, and headache frequency. Menstrual migraine is associated with low hemoglobin levels. A significant increase was found in VAS and HIT-6 scores with low ferritin levels. CONCLUSIONS: The presence and severity of anemia and iron deficiency do not affect the frequency and severity of migraine attacks in groups other than menstruation-related migraine. An inverse relationship was found between VAS, HIT-6, and ferritin levels. VAS was found to be more effective than HIT-6. © 2024 Verduci Editore s.r.l. All rights reserved.
dc.identifier.doi10.26355/eurrev_202402_35335
dc.identifier.endpage1001
dc.identifier.issn1128-3602
dc.identifier.issue3
dc.identifier.pmid38375703
dc.identifier.scopus2-s2.0-85185588879
dc.identifier.scopusqualityQ2
dc.identifier.startpage995
dc.identifier.urihttps://doi.org/10.26355/eurrev_202402_35335
dc.identifier.urihttps://hdl.handle.net/20.500.12462/21028
dc.identifier.volume28
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherVerduci Editore s.r.l
dc.relation.ispartofEuropean Review for Medical and Pharmacological Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250703
dc.subjectFerritin
dc.subjectIron deficiency anemia
dc.subjectMigraine
dc.titleAssociation between anemia severity and migraine in iron deficiency anemia
dc.typeArticle

Dosyalar